PERSPIRE: Preventing rehospitalization in lung transplant recipients through mHealth utilizing individualized rehabilitation prescriptions
Recruiting
99 years or below
All
40 participants needed
1 Location
Brief description of study
Lung transplant recipients have the highest risk of readmission after the index admission among solid organ transplant patients. We hypothesize that targeted, individualized rehabilitation plans will reduce the risk of unplanned readmission in the first year after lung transplantation.To address this hypothesis, we will conduct a prospective cohort study of lung transplant recipients at the University of Pennsylvania and the University of California San Francisco, utilizing the Aidcube application for targeted rehabilitation program development.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Lung Transplant; Complications
-
Age: 99 years or below
-
Gender: All
Updated on
19 Feb 2024.
Study ID: 831322
Find a site
,
Your Information has been sent successfully.
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Message For Non Enrolling By Invitation Trial
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code
or